Long QT syndrome in a patient with allergic rhinoconjunctivitis and auto-immune diabetes: Focus on the choice of anti-H1 drugs

European Annals of Allergy and Clinical Immunology

Volumn 38, Issue 10, 2006, Pages 347-350

  Moneret Vautrin, D A ^a,b   De Chillou, C ^a   Codreanu, A ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b Laboratory of Molecular Medecine and Therapeutics   (France)

Author keywords

Anti H1 drugs; Long QT syndrome

Indexed keywords

ANTIHISTAMINIC AGENT; ASTEMIZOLE; AZELASTINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; DESLORATADINE; DIPHENHYDRAMINE; EBASTINE; FEXOFENADINE; HYDROXYZINE; INSULIN; LEVOCETIRIZINE; ORPHENADRINE; TERFENADINE;

ADOLESCENT; ALLERGIC DISEASE; ALLERGY TEST; ANAMNESIS; AUTOIMMUNE DISEASE; CASE REPORT; CLINICAL FEATURE; DIABETES MELLITUS; DRUG CONTRAINDICATION; HUMAN; LONG QT SYNDROME; MALE; REVIEW; RHINOCONJUNCTIVITIS;

ADOLESCENT; ADRENERGIC BETA-ANTAGONISTS; ANTI-ASTHMATIC AGENTS; BUTYROPHENONES; CETIRIZINE; CONJUNCTIVITIS, ALLERGIC; CROMOLYN SODIUM; DIABETES MELLITUS, TYPE 1; HEART; HISTAMINE H1 ANTAGONISTS; HUMANS; LONG QT SYNDROME; MALE; PIPERAZINES; PIPERIDINES; RHINITIS, ALLERGIC, SEASONAL; TERFENADINE;

EID: 33846443989     PISSN: 03979148     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. Aliot E., Chauvin M., Daubert J.-C., Frank R., Jondeau J.-F., Leclercq J.-F., Le Heuzey J.-Y. - Indications du défibrillateur automatique implantable ventriculaire. Mise à jour de la version française. Arch Mal Cœur Vaisseaux 2006;99:141-54.
2. Important reference: recommendations by the French Society of Cardiology, placing implantable cardioverter defibrillators, Aliot. E et al. Arch Mal Cœur 2006;99:141-54.
3. Broadhurst P., Nathan A.-W. - Cardiac arrest in a young woman with the long QT syndrome and concomitant astemizole ingestion. Br Heart J 1993;70:469-70.
4. Davies A.-J., Harinda V., McEwan A., Chose R.-R. - Cardiotoxic effect with convulsions in terfenadine overdose. Br Med J 1989;298:325.
5. Denjoy I., Lupoglazoff J.-M., Guicheney P., Leenhardt A. - Syndrome du QT long congénital. AMC pratique 2002:11-12.
6. Fukushige T., Yoshinaga M., Shimago A., Nishi J., Kono Y., Nomura Y. et al. - Effect of age and overweight on the QT interval and the prevalence of long QT syndrome in children. Am J Cardiol 2002;89:395-8.
7. Gehanno P., Bremard-Oury C., Zeisser P. - Comparison of ebastine to cetirizine in seasonal allergic rhinitis in adults. Ann Allergy Asthma Immunol 1996;76:507-12.
8. Hanrahan J.-P., Choo P.-W., Carlson W., Greineder D., Faich G.-A. et al. - Terfenadine associated ventricular arrhythmias and QTc interval prolongation: a retrospective cohort comparison with other antihistamines among members of a health maintenance organization. Ann Epidemiol. 1995;5:201-9.
9. Le Heuzey J.-Y, Davy J.-M., Guicheney P., Le Marec H., Chevalier P., Denjoy I. et al. - Intervalle QT et médicaments. Arch Mal Cœur 1998;91:59-66.
10. Luzza F., Raffa S., Saporito F., Oreto G. - Torsades de pointes in congenital long QT syndrome following low-dose orphenadrine. Int J Clin Pract. 2006;60:606-8.
11. Monahan B.-P., Gerguson C.-L., Killeavy E.-S., Lloyd B.-K., Troy J et al. - Torsades de pointes occurring in association with terfenadine use. JAMA 1990;264:2788-90.
12. Moss A.-J., Morganroth J. - Cardiac effects of ebastine and other antihistamines in humans. Drug Saf 21 1999; Suppl 1:69-80; discussion 81-7.
13. Moss A.-J., Robinson J.-L. - The long-QT syndrome. Circulation 2002;105:784-6.
14. Passalacqua G., Bousquet J., Bachert C., Church M.-K., Bindslev-Jensen C., Nagy L. et al. - The clinical safety of H1-receptor antagonists. An EAACI position paper. Allergy 1996;51:666-75.
15. Priori S.-G., Schwartz P.-J., Napolitano C., Bloise R., Ronchetti E., Grillo M. et al. - Risk stratification in the long-QT syndrome. N Engl J Med 2003;348:1866-74.
16. Roden D.-M. - Drug-induced prolongation of the QT Interval. N Engl J Med 2004;350:1013-22.
17. Swims M.-P. - Potential terfenadine Fluoxetine interaction. Ann Pharmac. 1993;27:1404-5.
18. Yap Y.-G., Camm A.-J. - Potential cardiac toxicity of H1-antihistamines. Clin Allergy Immunol 2002;17:389-419. An in-depth review.